Table 1. Characteristics about 68 samples used for survival analysis.
| Clinicopathologicalvariables | NumberN=68 | Percentage |
| Gender | ||
| Male | 55 | 80.88 |
| Female | 13 | 19.12 |
| Age | ||
| ≤50 | 33 | 48.53 |
| >50 | 35 | 51.47 |
| AFP (ug/L) | ||
| ≤20 | 18 | 26.47 |
| >20 | 50 | 73.53 |
| HBV | ||
| Negative | 8 | 11.76 |
| Positive | 60 | 88.24 |
| HCV | ||
| Negative | 67 | 98.53 |
| Positive | 1 | 1.47 |
| Tumor size (cm) | ||
| ≤5 | 36 | 52.94 |
| >5 | 32 | 47.06 |
| Vascular invasion | ||
| No | 50 | 73.53 |
| Yes | 18 | 26.47 |
| Differentiation | ||
| High | 9 | 13.23 |
| Moderately | 31 | 45.6 |
| Low | 28 | 41.17 |
| Distant metastasis | ||
| No | 60 | 88.24 |
| Yes | 8 | 11.76 |
| TNM stage | ||
| T1 | 14 | 20.59 |
| T2-T3-T4 | 54 | 79.41 |
| BCLC stage | ||
| 0+A | 42 | 61.76 |
| B+C | 26 | 38.24 |
| Adjuvant TACE | ||
| No | 52 | 76.47 |
| Yes | 16 | 23.53 |